BiotechTube
Home/Pipeline/Biosimilar Products Portfolio

Biosimilar Products Portfolio

Not Specified

Not SpecifiedActive

Key Facts

Indication
Not Specified
Phase
Not Specified
Status
Active
Company
Harvest Moon Pharmaceuticals USA

About Harvest Moon Pharmaceuticals USA

Harvest Moon Pharmaceuticals USA is a private, commercial-stage company specializing in complex generics and biosimilars, with a legacy pipeline acquired from TCI Generics. It operates a development and manufacturing model aimed at out-licensing products to partners worldwide, supported by an international sales force via PanGenerika B.V. The company's strategy targets the high-value, difficult-to-manufacture segment of the generic drug market to provide lower-cost alternatives to branded biologics and complex therapeutics.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved